Novel Immunotherapeutics for Treatment of Glioblastoma: The Last Decade of Research
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Novel Immunotherapeutics for Treatment of Glioblastoma: The Last Decade of Research
Authors
Keywords
-
Journal
CANCER INVESTIGATION
Volume -, Issue -, Pages 1-7
Publisher
Informa UK Limited
Online
2019-01-12
DOI
10.1080/07357907.2018.1479414
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The development of dendritic cell vaccine-based immunotherapies for glioblastoma
- (2017) David A. Reardon et al. Seminars in Immunopathology
- Recent advances and future of immunotherapy for glioblastoma
- (2016) Neha Kamran et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Novel vaccines for glioblastoma: clinical update and perspective
- (2016) Evan K Winograd et al. Immunotherapy
- Advances in HSP27 and HSP90-targeting strategies for glioblastoma
- (2016) Randy van Ommeren et al. JOURNAL OF NEURO-ONCOLOGY
- ATIM-31. ALLOGENEIC TUMOR LYSATE / AUTOLOGOUS DENDRITIC CELL VACCINES IN NEWLY DIAGNOSED GLIOBLASTOMA: CLINICAL TRIAL MC1272
- (2016) Ian F. Parney et al. NEURO-ONCOLOGY
- IMST-16. TRANSLATABLE RNA NANOPARTICLES SUPPLANT DENDRITIC CELL VACCINES IN CELLULAR IMMUNOTHERAPY
- (2016) Elias Sayour et al. NEURO-ONCOLOGY
- Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
- (2016) Christine E. Brown et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bioactivity and Safety of IL13R 2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent Glioblastoma
- (2015) C. E. Brown et al. CLINICAL CANCER RESEARCH
- Armed hunter killers: discerning the role of adoptive T-cell transfer for glioblastoma
- (2015) Heba Samaha et al. Immunotherapy
- Heat shock protein vaccines against glioblastoma: from bench to bedside
- (2015) Leonel Ampie et al. JOURNAL OF NEURO-ONCOLOGY
- Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients
- (2015) Duane A. Mitchell et al. NATURE
- Prospects of immune checkpoint modulators in the treatment of glioblastoma
- (2015) Matthias Preusser et al. Nature Reviews Neurology
- Adenovirus-mediated delivery of herpes simplex virus thymidine kinase administration improves outcome of recurrent high-grade glioma
- (2015) Nan Ji et al. Oncotarget
- Durable Therapeutic Efficacy Utilizing Combinatorial Blockade against IDO, CTLA-4, and PD-L1 in Mice with Brain Tumors
- (2014) D. A. Wainwright et al. CLINICAL CANCER RESEARCH
- Heat-shock proteins-based immunotherapy for advanced melanoma in the era of target therapies and immunomodulating agents
- (2014) Giulio Tosti et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Vaccine therapies for patients with glioblastoma
- (2014) Eli T. Sayegh et al. JOURNAL OF NEURO-ONCOLOGY
- Programmed death ligand 1 expression and tumor-infiltrating lymphocytes in glioblastoma
- (2014) Anna Sophie Berghoff et al. NEURO-ONCOLOGY
- Autoimmunity as a Double Agent in Tumor Killing and Cancer Promotion
- (2014) Kevin H. Toomer et al. Frontiers in Immunology
- Therapeutic vaccination against autologous cancer stem cells with mRNA-transfected dendritic cells in patients with glioblastoma
- (2013) Einar Osland Vik-Mo et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Active immunotherapy using dendritic cells in the treatment of glioblastoma multiforme
- (2013) Amade Bregy et al. CANCER TREATMENT REVIEWS
- EGFRvIII mCAR-Modified T-Cell Therapy Cures Mice with Established Intracerebral Glioma and Generates Host Immunity against Tumor-Antigen Loss
- (2013) J. H. Sampson et al. CLINICAL CANCER RESEARCH
- Anti-PD-1 Blockade and Stereotactic Radiation Produce Long-Term Survival in Mice With Intracranial Gliomas
- (2013) Jing Zeng et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Heat-shock protein peptide complex–96 vaccination for recurrent glioblastoma: a phase II, single-arm trial
- (2013) Orin Bloch et al. NEURO-ONCOLOGY
- The natural killer cell response and tumor debulking are associated with prolonged survival in recurrent glioblastoma patients receiving dendritic cells loaded with autologous tumor lysates
- (2013) Serena Pellegatta et al. OncoImmunology
- Phase I/IIa study of intratumoral/intracerebral or intravenous/intracerebral administration of Parvovirus H-1 (ParvOryx) in patients with progressive primary or recurrent glioblastoma multiforme: ParvOryx01 protocol
- (2012) Karsten Geletneky et al. BMC CANCER
- Phase I trial of a multi-epitope-pulsed dendritic cell vaccine for patients with newly diagnosed glioblastoma
- (2012) Surasak Phuphanich et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Individual Patient-Specific Immunity against High-Grade Glioma after Vaccination with Autologous Tumor Derived Peptides Bound to the 96 KD Chaperone Protein
- (2012) C. A. Crane et al. CLINICAL CANCER RESEARCH
- Immune Response in Patients With Newly Diagnosed Glioblastoma Multiforme Treated With Intranodal Autologous Tumor Lysate-dendritic Cell Vaccination After Radiation Chemotherapy
- (2011) Camilo E. Fadul et al. JOURNAL OF IMMUNOTHERAPY
- Gene Expression Profile Correlates with T-Cell Infiltration and Relative Survival in Glioblastoma Patients Vaccinated with Dendritic Cell Immunotherapy
- (2010) Robert M. Prins et al. CLINICAL CANCER RESEARCH
- Greater chemotherapy-induced lymphopenia enhances tumor-specific immune responses that eliminate EGFRvIII-expressing tumor cells in patients with glioblastoma
- (2010) J. H. Sampson et al. NEURO-ONCOLOGY
- Survival analysis of 205 patients with glioblastoma multiforme: Clinical characteristics, treatment and prognosis in China
- (2009) Xiangyu Ma et al. JOURNAL OF CLINICAL NEUROSCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now